Volitionrx Limited's ability to collect accounts receivable sequentially worsen to 8.5, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Volitionrx Limited's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 43 days, from 40 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 150 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1342, from overall ranking in the first quarter 2026 at 2230.

What is Receivable Turnover Ratio?
What is Volitionrx Limited Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

VNRX Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	46.29 %	34.29 %	187.42 %	-1.13 %	14.04 %
Y / Y Revenue Change	-1.97 %	299.81 %	133.25 %	32.19 %	2.75 %
Receivable Turnover Ratio (TTM)	8.5	9.23	6.88	7.39	6.59
VNRX's Total Ranking	# 1342	# 2230	# 1824	# 2104	# 2096
Accounts Receivable average collection period days	43	40	53	49	55
Seq. Receivable Change	9.96 %	-20.63 %	2.82 %	63.02 %	0.94 %
Seq. Revenue Change	-59.53 %	120.36 %	-28.73 %	54.24 %	65.06 %

Receivable Turnover Company Ranking
Within:	No.
In Vitro & In Vivo Diagnostic Substances Industry	# 2
Healthcare Sector	# 151
Overall Market	# 1342

Receivable Turnover Ratio Statistics
High	Average	Low
23.19	7.31	4.82
(Sep 30 2020)		(Dec 31 2020)

VNRX Company Profile • Back to VNRX Efficiency Comparisons • Compare VNRX Receivables Turnover Ratio to its Competitors

Financial Statements
Volitionrx Limited's Accounts Receivable	$ 0 Millions	Visit VNRX's Balance sheet
Volitionrx Limited's Sales TTM	$ 2 Millions	Visit VNRX's Income Statement
Sources of VNRX's Revenues		Visit VNRX's Sales by Geography

Other Accounts Receivable Turnover Ratios
In Vitro & In Vivo Diagnostic Substances Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
VNRX's Receivable Turnover Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
VNRX's Growth Rates	VNRX's Roa	VNRX's Inventory Turnover Ratio	VNRX's Dividend Comparisons
VNRX's Profitability Ratios	VNRX's Roi	VNRX's Asset Turnover Ratio	VNRX's Dividend Growth
VNRX's Valuation Ratios	VNRX's Roe	VNRX's Financial Strength Ratios	VNRX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Sonida Senior Living Inc	22.59	$ 525.973 Millions	$ 23.283 Millions
U S Physical Therapy Inc	22.40	$ 812.203 Millions	$ 36.251 Millions
Nutriband Inc	22.15	$ 1.618 Millions	$ 0.073 Millions
Ginkgo Bioworks Holdings Inc	20.32	$ 111.863 Millions	$ 5.506 Millions
Lineage Cell Therapeutics Inc	20.02	$ 13.083 Millions	$ 0.654 Millions
Hims and Hers Health Inc	19.65	$ 2,578.494 Millions	$ 131.228 Millions
Bausch Health Companies Inc	18.42	$ 10,853.000 Millions	$ 589.250 Millions
Lipocine Inc	18.36	$ 1.569 Millions	$ 0.085 Millions
Nrx Pharmaceuticals Inc	17.25	$ 3.394 Millions	$ 0.197 Millions
Polomar Health Services, Inc.	17.19	$ 3.172 Millions	$ 0.185 Millions
Anika Therapeutics Inc	16.70	$ 121.370 Millions	$ 7.266 Millions
Vireo Growth Inc.	16.69	$ 511.706 Millions	$ 30.659 Millions
Lifemd Inc	16.48	$ 163.363 Millions	$ 9.915 Millions
Protagonist Therapeutics inc	15.97	$ 281.992 Millions	$ 17.661 Millions
Neuraxis Inc	15.53	$ 5.316 Millions	$ 0.342 Millions
Agenus Inc	15.44	$ 132.693 Millions	$ 8.595 Millions
Longeveron Inc	15.03	$ 1.187 Millions	$ 0.079 Millions
Medicinova Inc	15.02	$ 0.920 Millions	$ 0.061 Millions
Voyager Therapeutics Inc	14.71	$ 34.459 Millions	$ 2.343 Millions
Halozyme Therapeutics Inc	14.68	$ 1,663.738 Millions	$ 113.332 Millions
Dar Bioscience Inc	14.57	$ 1.345 Millions	$ 0.092 Millions
Nexgel Inc	14.52	$ 11.810 Millions	$ 0.813 Millions
China Pharma Holdings Inc	14.46	$ 3.914 Millions	$ 0.271 Millions
Lftd Partners Inc	14.13	$ 35.335 Millions	$ 2.500 Millions
Talkspace Inc	14.09	$ 246.631 Millions	$ 17.506 Millions
Lifestance Health Group Inc	14.07	$ 1,584.834 Millions	$ 112.665 Millions
Ataibeckley Inc	13.83	$ 4.473 Millions	$ 0.324 Millions
Amneal Pharmaceuticals Inc	13.83	$ 3,117.474 Millions	$ 225.492 Millions
Arvinas Inc	13.49	$ 316.700 Millions	$ 23.475 Millions
Rosecliff Acquisition Corp I	13.43	$ 16.467 Millions	$ 1.226 Millions

Date modified: 2026-09-03T12:22:38+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.